Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Surmodics (SRDX)
NASDAQ:SRDX
SurModics (SRDX) Stock Price & Analysis
106 Followers
SRDX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$16.79 - $39.41
Previous Close$32.45
Volume26.65K
Average Volume (3M)72.16K
Market Cap
$468.58M
Enterprise Value$451.28M
Total Cash (Recent Filing)$40.94M
Total Debt (Recent Filing)$29.48M
Price to Earnings (P/E)33.9
Beta1.16
Next Earnings
Jul 31, 2024EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.96
Shares Outstanding14,260,000
10 Day Avg. Volume103,171
30 Day Avg. Volume72,160
Standard Deviation0.13
R-Squared0.17
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)8.25
Price to Sales (P/S)14.48
Price to Cash Flow (P/CF)15.50
P/FCF Ratio16.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.62
Enterprise Value/Gross Profit4.19
Enterprise Value/Ebitda13.91
Forecast
1Y Price Target
$63.00Price Target Upside91.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
SurModics News
PremiumCompany Announcements
Surmodics Shareholders Approve Directors and Fiscal Oversight
Bulls Say, Bears Say
Bulls Say
Financial PerformanceQ2 financial results were much better than expected with significant revenue and non-GAAP EPS beats.
Guidance UpdateCompany's FY/24 revenue and non-GAAP EPS guidance have been raised due to robust Q2 results and positive product momentum.
Product ImpactIntroduction of new products such as SurVeil DCB, Pounce thrombectomy, and Sublime radial access are materially contributing to strong financial performance.
Bears Say
Analyst RecommendationAnalyst has lowered the price target to $43 from $47 due to peer multiple compression.
Cash FlowCash flow from operations was worse than expected, coming in at -$8.8 million.
Financial PerformanceExcluding SurVeil license fees, revenue growth slowed to 19% from 25%.
---
Ownership Overview
51.19% Insiders
20.30% Mutual Funds
18.32% Other Institutional Investors
10.20% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRDX FAQ
What was Surmodics’s price range in the past 12 months?
Surmodics lowest stock price was $16.79 and its highest was $39.41 in the past 12 months.
What is Surmodics’s market cap?
Currently, no data Available
When is Surmodics’s upcoming earnings report date?
Surmodics’s upcoming earnings report date is Jul 31, 2024 which is in 78 days.
How were Surmodics’s earnings last quarter?
Surmodics released its earnings results on May 01, 2024. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of -$0.35 by $0.42.
Is Surmodics overvalued?
According to Wall Street analysts Surmodics’s price is currently Undervalued.
Does Surmodics pay dividends?
Surmodics does not currently pay dividends.
What is Surmodics’s EPS estimate?
Surmodics’s EPS estimate is -$0.34.
How many shares outstanding does Surmodics have?
Surmodics has 14,260,000 shares outstanding.
What happened to Surmodics’s price movement after its last earnings report?
Surmodics reported an EPS of $0.07 in its last earnings report, beating expectations of -$0.35. Following the earnings report the stock price went up 29.739%.
Which hedge fund is a major shareholder of Surmodics?
Among the largest hedge funds holding Surmodics’s share is Royce & Associates LLC. It holds Surmodics’s shares valued at 15M.
---
SurModics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$63.00 (91.72% Upside)
$63.00 (91.72% Upside)
Blogger Sentiment
Bullish
SRDX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 130.2K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
68.83%
12-Months-Change
Fundamentals
Return on Equity
11.92%
Trailing 12-Months
Asset Growth
10.02%
Trailing 12-Months
Company Description
Surmodics
SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
---
SRDX Earnings Call
Q2 2024
0:00 / 0:00
---
SRDX Stock 12 Month Forecast
Average Price Target
$63.00
▲(91.72% Upside)
Technical Analysis
Best Analysts Covering SRDX
1 Year
1 Year Success Rate
15/34 ratings generated profit
1 Year Average Return
-0.49%
reiterated a buy rating 13 days ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 44.12% of your transactions generating a profit, with an average return of -0.49% per trade.
---